Ahmet Bolat

Ahmet Bolat

Auto-generated profile, based on publicly available information

Ahmet Bolat

Department of Child Health and Diseases, University of Health Sciences Gülhane Medical Faculty, Keçiören, Ankara, Turkey

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 May 2023 in Turkish Archives of Pediatrics
Verified
Journal Article
Open access
HBHarun Bayrak
Harun Bayrak
DÖDidem Öztürk
Didem Öztürk
ABAhmet Bolat
Ahmet Bolat
B1Bülent Ünay 1
Bülent Ünay 1
Objective: Coronavirus disease 2019 (COVID-19) infection is seen in all age groups, and its symptoms are very variable. The course of the disease can be asymptomatic or mortal. In pediatric patients, vitamin D is thought to be protective against (COVID-19) with its immunomodulator, antiviral, anti-inflammatory, and epithelial integrity properties. Our aim is to investigate the relationship between (COVID-19) infection and vitamin D level. Materials and Methods: We included (COVID-19) patients between 1 month and 18 years of age and healthy control groups. We compared epidemiological, clinical, laboratory, and imaging findings in patients. Results: One hundred forty-nine patients were evaluated in our study. Seventy-three (49%) of them were (COVID-19)-positive patients and 76 (51%) of them were healthy control group. The mean 25(OH)-D vitamin level was 15.80 ng/mL (5‐41.56) in (COVID-19) patients and 21.51 ng/mL (5-69.80) in the control group. Vitamin D level was shown to be statistically significantly lower in coronavirus disease 2019 patients (P < .001). It was observed that myalgia was more common in patients with low 25(OH)-D levels (P < .048). Conclusion: Our study is one of the rare studies examining the relationship between (COVID19) and 25(OH)-D vitamins in the pediatric age group. Children with (COVID-19) have a lower 25(OH)-D vitamin level than the control group. Cite this article as: Bayrak H, Öztürk D, Bolat A, Ünay B. Association between vitamin D levels and COVID-19 Infection in children: A case-control study. Turk Arch Pediatr. 2023;58(3):250-255.

16 September 2021 in European Archives of Oto-Rhino-Laryngology
Verified
Journal Article
Closed access
PDF file
NENazli Ercan
Nazli Ercan
FDFevzi Demirel
Fevzi Demirel
SYSait Yeşillik
Sait Yeşillik
ABAhmet Bolat
Ahmet Bolat
ÖKÖzgür Kartal
Özgür Kartal


27 February 2023 in Journal of Clinical Research in Pediatric Endocrinology
Verified
Journal Article
Open access
ABAhmet Bolat
Ahmet Bolat
CZCengiz Zeybek
Cengiz Zeybek
OGOrhan Gürsel
Orhan Gürsel
OAOnur Akın
Onur Akın
MTMehmet Emre Taşçılar
Mehmet Emre Taşçılar
Premature adrenarche (PA) has been associated with an increase in adrenal androgens, and the hyperandrogenic hormonal environment is known to lead to increased platelet (PLT) aggregation. Here, we evaluated the effects of PA on PLT aggregation in PLT-rich plasma samples from female patients. The study included 40 female patients diagnosed with PA between February, 2014 and June, 2018 and 30 healthy female individuals as a control group. Adenosine diphosphate (ADP) and collagen-induced PLT aggregation were studied via the photometric aggregometry method. There were no significant differences in the PLT count or volume values between those participants with PA and the control group. Additionally, the ADP-induced maximum aggregation time, value, and slope values did not significantly differ between the patient and control groups (p>0.05). However, the collagen-induced maximum aggregation time, value, and slope values were significantly higher in the studygroup (p<0.001). Increased collagen-induced PLT aggregation was detected in female patients with PA. As PA is associated with a higher risk of cardiovascular events later in life, close follow-up of PA in this respect may be beneficial.

12 January 2023 in Journal of Health Sciences and Medicine
Verified
Journal Article
Open access
PDF file
ABAhmet Bolat
Ahmet Bolat
Aim: Pediatric forensic cases have an important share in pediatric emergency service admissions. These require immediate treatment as they can lead to pediatric morbidity and mortality. In this study, a retrospective analysis of pediatric patients admitted to the emergency department due to acute forensic events was performed, and it was aimed to contribute to the data collected in Turkey by evaluating the results along with the results of other studies. Material and Method: All pediatric forensic cases admitted to the Pediatric Emergency Service of the Gülhane Training and Research Hospital between November 2016 and January 2018 were retrospectively analyzed. The demographic characteristics, forensic events, intoxication agents, hospitalization statuses and clinical follow-ups of the cases were recorded. Results: Among the 819 pediatric forensic cases admitted to the Pediatric Emergency Service, 393 (48%) were male, and 426 (52%) were female. The cases were aged between 0 and 18, with a mean age of 7.75±6.87 years. The majority of the patients were in the 0-2 age group (n=349, 42.6%). Case admissions were more frequent in winter months (n= 240; 29.3%), and most admissions were made in December (n=92; 11.2%). The days of the week with the highest frequencies of admissions were Wednesday (n=138, 16.8%) and Monday (n=134, 16.3%). The hours of the day with the highest frequencies of admissions were between 18:00 and 24:00 (n=309; 37.72%). Drug intoxication (47.13%) was found to be the most frequently encountered reason for the admission of the cases. While 69.47% (n=569) of the cases were treated as outpatients, 29.42% (n=241) were treated as inpatients, and the mortality rate in the sample was 0.6%. Conclusion: Most causes of pediatric forensic events are preventable. Therefore, a safe environment should be provided by taking effective protective measures, and strategies that include education in which families and children will actively participate should be developed.

7 November 2022 in Journal of Pediatric Infectious Diseases
Verified
Journal Article
Closed access
PDF file
ABAhmet Bolat
Ahmet Bolat
DYDeniz Yaprak
Deniz Yaprak
MAMelike Arslan
Melike Arslan
ABAyşe Büyükcam
Ayşe Büyükcam
NBNecati Balamtekin
Necati Balamtekin
Objective There are many adverse effects of drugs used to eradicate Helicobacter pylori, and reconstructing the microbiota by external ingestion of probiotics seems to have good effects on H. pylori eradication and prevents side effects.Methods The study included 161 outpatients aged between 8 and 18 years diagnosed with H. pylori gastritis in the Gülhane Training and Research Hospital Pediatric Gastroenterology unit from June 1, 2018, through March 31, 2020, and patients were randomized into two groups. Eighty patients in the probiotic group (first group) received H. pylori eradication therapy for 14 days; additionally, Bifidobacterium lactis B94 was administered for 14 days for eradication of H. pylori. Eighty-one patients in the standard therapy group (second group) received the same eradication therapy but no probiotics. All patients were asked to complete a detailed questionnaire regularly, including changes in symptoms and side effects of drugs on days 0, 7, and 14 of treatment. The eradication success was checked with the H. pylori stool antigen test kit 8 weeks after completion of the treatment regimen.Results The mean age of the patients was 14.2 ± 2.9 years, and 88 (64.7%) were female. The eradication rates were similar between the standard therapy and the probiotic groups by intention-to-treat analysis (p = 0.930). In order of frequency, the most common eradication treatment–related side effects were abdominal pain, taste abnormalities, and anorexia. In addition, therapy-related epigastric pain and flatulence were similar initially (p > 0.05) but seemed to be significantly lower in the probiotic group than in the standard therapy group on days 7 and 14 (p < 0.05).Conclusions Our results suggest that additional probiotic supplementation has not changed the eradication rates but seems to reduce some specific gastrointestinal adverse events in children with H. pylori infections treated with a bismuth-based quadruple eradication regimen. More extensive randomized controlled trials are needed to explain probiotics' effects on H. pylori eradication and drug side effects.